Sign In   |   Register
News: Publications

New EAS Consensus Paper out - update on PCSK9 on practical clinical guidance

Wednesday 18 October 2017   (0 Comments)
Share |

Today The European Society of Cardiology/European Atherosclerosis Society (ESC/EAS) Task Force has published updated clinical guidance for the use of PCSK9 inhibitors. This document supersedes the previous guidance issued by this group.


Landmesser U, Chapman MJ, Stock JK, Amarenco P, Belch JJF, Borén J, Farnier M, Ference BA, Gielen S, Graham I, Grobbee DE, Hovingh GK, Lüscher TF, Piepoli MF, Ray KK, Stroes ES, Wiklund O, Windecker S, Zamorano JL, Pinto F, Tokgözoğlu L, Bax JJ, Catapano AL. 2017 Update of ESC/EAS Task Force on Practical Clinical Guidance for PCSK9 inhibition in patients with ASCVD or in familial hypercholesterolaemia.
European Heart Journal 2017;

Access the Consensus Statement in full >>

To the editorial by Jane K. Stock >>

Membership Software Powered by YourMembership  ::  Legal